Living Liver Donor With Fasciola Hepatica: First Case Report in the Literature

Basit Öğe Kaydı
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridBAYINDIR, Yasar/0000-0003-3930-774X
dc.authoridSAHIN, TEVFIK TOLGA/0000-0002-9132-6115
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidSAHIN, TEVFIK TOLGA/W-2539-2017
dc.contributor.authorAkbulut, Sami
dc.contributor.authorSahin, Tevfik Tolga
dc.contributor.authorKolu, Mehmet
dc.contributor.authorIsik, Burak
dc.contributor.authorBayindir, Yasar
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:49:25Z
dc.date.available2024-08-04T20:49:25Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe major advantage of preoperative magnetic resonance cholangiopancreatography is that living liver donor candidates with complicated biliary tracts may not be exposed to unnecessary laparotomy. To the best of our knowledge, the case presented here features a condition so far not seen by the Liver Transplantation Society. A 27-year-old woman who presented to our clinic as a living liver donor candidate was evaluated but did not have a preoperative magnetic resonance cholangiopancreatography due to technical factors. After parenchymal transection, the right hepatic duct was incised just distal to the bifurcation when 8 fasciola hepatica parasites left the orifice of the remnant bile duct. The common bile duct was then irrigated, and the remnant bile duct orifice was closed, followed by a cholangiography, which showed no suspicious lesions in the biliary tracts. In addition, no suspicious lesions were identified during the postoperative cholangiography of the graft implanted in the recipient. The donor and recipient had postoperative enzyme-linked immunosorbent assay immunoglobulin G antibody titers of 12 and 4 U/mL (cutoff value = 10) for fasciola hepatica, respectively. Both the recipient and the donor received 2 doses of triclabendazole (10 mg/kg) during the postoperative period.en_US
dc.identifier.doi10.6002/ect.2017.0318
dc.identifier.endpage279en_US
dc.identifier.issn1304-0855
dc.identifier.issn2146-8427
dc.identifier.issue3en_US
dc.identifier.pmid30119621en_US
dc.identifier.scopus2-s2.0-85102911944en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage276en_US
dc.identifier.urihttps://doi.org/10.6002/ect.2017.0318
dc.identifier.urihttps://hdl.handle.net/11616/99840
dc.identifier.volume19en_US
dc.identifier.wosWOS:000625286000015en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBaskent Univen_US
dc.relation.ispartofExperimental and Clinical Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLiver flukesen_US
dc.subjectLiving-donor hepatectomyen_US
dc.subjectLiving-donor liver transplantationen_US
dc.subjectParasitic infectionen_US
dc.titleLiving Liver Donor With Fasciola Hepatica: First Case Report in the Literatureen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu